Apolipoprotein synthesis in nonalcoholic steatohepatitis

Hepatology

Volumn 35, Issue 4, 2002, Pages 898-904

  Charlton, Michael ^a   Sreekumar, Raghavakaimal ^a   Rasmussen, Deborah ^a   Lindor, Keith ^a   Nair, K Sreekumaran ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN B100; FIBRINOGEN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY LIVER; HUMAN; LIVER METABOLISM; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; PROTEIN SYNTHESIS;

EID: 0036207720     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.32527     Document Type: Article

References (47)

1. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
2. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
3. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients
4. Nonalcoholic steatohepatitis: An expanded clinical entity
5. Nonalcoholic steatohepatitis: A study of 49 patients
6. Idiopathic steatohepatitis in childhood: A multicenter retrospective study
7. Liver pathology in morbidly obese patients with and without diabetes
8. The natural history of nonalcoholic fatty liver: A follow-up study
9. The clinical associations with hepatic steatosis: A retrospective study
10. The apolipoprotein B gene is constitutively expressed in HepG2 cells: Regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life
11. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells
12. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals
13. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM
14. The role of ultrasonography in the diagnosis of diffuse liver disease
15. Quantitative estimation of attenuation in ultrasound video images: Correlation with histology in diffuse liver disease
16. Dual-energy CT in the diagnosis and quantification of fatty liver: Limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload
17. Computer image analysis of ultrasound images for discriminating and grading liver parenchyma disease employing a hierarchical decision tree scheme and the multilayer perception neural network classifier
18. Hypoechoic lesions in the "bright liver": A reliable indicator of fatty change. A prospective study
19. Detection and differentiation of diffuse liver disease by quantitative echography. A retrospective assessment
20. Echographic tissue characterization in diffuse parenchymal liver disease: Correlation of image structure with histology
21. Ultrasonographic diagnosis of mild fatty infiltration of the liver with the difference between liver and kidney echolevels
22. Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-3C] leucine
23. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man
24. High performance liquid chromatographic determination of amino acids in the picomole range
25. Routine measurement of plasma catecholamines in clinical pharmacology by high-performance liquid chromatography with electrochemical detection
26. Sequential purification of human apolipoprotein B-100, albumin, and fibrinogen by immunoaffinity chromatography for measurement of protein synthesis
27. Isolation and characterization of apolipoprotein B-48 and B-100 very-low-density lipoproteins from type III hyperlipoproteinemic subjects
28. Regulation of leucine metabolism in man: A stable isotope study
29. Mass spectrometric assay of stable isotopic enrichment for the estimation of protein turnover in man
30. Very-low-density lipoprotein-apolipoprotein B turnover studies in normal subjects: A stable isotope study
31. Precursor pools of protein synthesis: A stable isotope study in a swine model
32. Plasma triglyceride transport kinetics in diabetes mellitus
33. Apolipoprotein metabolism: A stable-isotope approach
34. Direct measurement of apolipoprotein B synthesis in human very-low-density lipoprotein using stable isotopes and mass spectrometry
35. Does long-term home parenteral nutrition in adult patients cause chronic liver disease?
36. Hepatobiliary complications in adults receiving nutrition support
37. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM
38. Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans
39. Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans
40. Regulation of hepatic very-low-density lipoprotein secretion in rats fed on a diet high in unsaturated fat
41. Regulation of VLDL secretion in primary culture of rat hepatocytes: Involvement of cAMP and cAMP-dependent protein kinases
42. IGF-I treatment in adults with type 1 diabetes: Effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp
43. Correlative factors of insulin resistance in essential hypertension
44. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion
45. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus
46. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus
47. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors